The Cardiac Mapping Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Cardiac Mapping market has experienced significant growth in the past years. The market size is projected to increase from $2.3 billion in 2024 to $2.48 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%.
The Cardiac Mapping market is predicted to reach a size of $3.29 billion in 2029, with a compound annual growth rate (CAGR) of 7.3%.
Download Your Free Sample of the 2025 Cardiac Mapping Market Report and Uncover Key Trends Now!The drivers in the cardiac mapping market are:
• Introduction and utilization of catheter ablation techniques
• Development and application of 3D mapping systems
• Technological improvements in imaging technologies
• Rising prevalence of cardiac arrhythmias and corresponding treatments
• Increasing preference and growth of minimally invasive procedures in cardiac care.
The cardiac mapping market covered in this report is segmented –
1) By Type: Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems
2) By Indications: Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Other Indications
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users
The trends in the cardiac mapping market are:
• The market is incorporating artificial intelligence in cardiac mapping.
• Real-time 3D mapping systems are becoming increasingly popular.
• There is a trend towards improved catheter technologies.
• The use of cloud-based data analysis and enhanced electrophysiology software are significant emerging trends.
The major players in the cardiac mapping market are:
• Johnson & Johnson
• Abbott Laboratories
• Medtronic plc
• Koninklijke Philips N
North America was the largest region in the cardiac mapping market in 2023